Filing Details
- Accession Number:
- 0001640334-19-000793
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2019-05-09 16:05:48
- Reporting Period:
- 2019-05-02
- Accepted Time:
- 2019-05-09 16:05:48
- Original Submission Date:
- 2019-05-06
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1711754 | Inmune Bio Inc. | INMB | Biological Products, (No Disgnostic Substances) (2836) | 475205835 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1767280 | Joseph Raymond Tesi | C/O Inmune Bio Inc. 1224 Prospect Street, Suite 150 La Jolla CA 92037 | President & Ceo | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-05-02 | 11,100 | $9.00 | 1,526,933 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- Includes 11,100 shares of the Issuer's common stock acquired by the Reporting Person in connection with a private placement effected as of May 2, 2019.This amendment was filed to correct the purchase price of the securities acquired by the Reporting Person.